CIK: 0001782539 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 10, 2022
Total Value ($000): $156,679 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KARUNA THERAPEUTICS INC | 241,639 | $54,352 | 34.7% | $121.31 | — | COM | 48576A100 |
| ILMN | ILLUMINA INC | 119,196 | $22,741 | 14.5% | $459.88 | -57.0% | COM | 452327109 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 510,978 | $22,631 | 14.4% | $30.00 | +62.6% | COM | 413197104 |
| — | EXSCIENTIA PLC | 853,050 | $7,004 | 4.5% | $18.64 | — | ADS | 30223G102 |
| — | SEAGEN INC | 47,096 | $6,444 | 4.1% | $154.22 | — | COM | 81181C104 |
| — | SOMALOGIC INC | 1,696,558 | $4,920 | 3.1% | $12.39 | — | CLASS A COM | 83444K105 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $4,729 | 3.0% | $17.30 | -38.7% | COM CL A | 753018100 |
| XENE | XENON PHARMACEUTICALS INC | 114,380 | $4,129 | 2.6% | $18.43 | +95.1% | COM | 98420N105 |
| — | EARGO INC | 2,886,724 | $3,031 | 1.9% | $39.91 | — | COM | 270087109 |
| REPL | REPLIMUNE GROUP INC | 155,199 | $2,680 | 1.7% | $17.60 | +8.3% | COM | 76029N106 |
| INCY | INCYTE CORP | 34,391 | $2,292 | 1.5% | $67.41 | +9.6% | COM | 45337C102 |
| — | CHINOOK THERAPEUTICS INC | 113,950 | $2,240 | 1.4% | $19.66 | — | COM | 16961L106 |
| TRDA | ENTRADA THERAPEUTICS INC | 141,593 | $2,232 | 1.4% | $9.39 | — | COM | 29384C108 |
| — | IVERIC BIO INC | 111,984 | $2,009 | 1.3% | $9.62 | — | COM | 46583P102 |
| — | CHEMOCENTRYX INC | 35,830 | $1,851 | 1.2% | $25.06 | — | COM | 16383L106 |
| — | BOLT BIOTHERAPEUTICS INC | 1,166,952 | $1,727 | 1.1% | $15.46 | — | COM | 097702104 |
| ONC | BEIGENE LTD | 12,022 | $1,621 | 1.0% | $265.35 | — | SPONSORED ADR | 07725L102 |
| KALV | KALVISTA PHARMACEUTICALS INC | 78,720 | $1,142 | 0.7% | $26.16 | -46.6% | COM | 483497103 |
| — | SATSUMA PHARMACEUTICALS INC | 177,900 | $1,067 | 0.7% | $4.92 | — | COM | 80405P107 |
| GRTX | GALERA THERAPEUTICS INC | 613,223 | $1,067 | 0.7% | $8.13 | -82.6% | COM | 36338D108 |
| EXEL | EXELIXIS INC | 64,200 | $1,007 | 0.6% | $23.32 | -17.2% | COM | 30161Q104 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 144,840 | $841 | 0.5% | $24.13 | -76.2% | COM | 69404D108 |
| — | DBV TECHNOLOGIES S A | 370,950 | $657 | 0.4% | $5.33 | — | SPONSORED ADR | 23306J101 |
| — | 2SEVENTY BIO INC | 40,273 | $586 | 0.4% | $17.06 | — | COMMON STOCK | 901384107 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 6,115 | $518 | 0.3% | $82.51 | +7.9% | COM | 09061G101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 29,984 | $491 | 0.3% | $20.11 | -19.5% | COM | 004225108 |
| ASND | ASCENDIS PHARMA A/S | 4,168 | $430 | 0.3% | $134.52 | — | SPONSORED ADR | 04351P101 |
| ALXO | ALX ONCOLOGY HLDGS INC | 41,950 | $401 | 0.3% | $60.98 | -80.9% | COM | 00166B105 |
| ARGX | ARGENX SE | 1,110 | $392 | 0.3% | $350.44 | — | SPONSORED ADR | 04016X101 |
| — | OTONOMY INC | 851,000 | $251 | 0.2% | $2.23 | — | COM | 68906L105 |
| RLMD | RELMADA THERAPEUTICS INC | 5,642 | $209 | 0.1% | $27.70 | 0.0% | COM | 75955J402 |
| — | REATA PHARMACEUTICALS INC | 8,265 | $208 | 0.1% | $141.56 | — | CL A | 75615P103 |
| — | FIBROGEN INC | 14,756 | $192 | 0.1% | $12.00 | — | COM | 31572Q808 |
| — | AFFIMED N V | 81,172 | $167 | 0.1% | $4.37 | — | COM | N01045108 |
| KOD | KODIAK SCIENCES INC | 19,622 | $152 | 0.1% | $81.98 | -88.1% | COM | 50015M109 |
| ABCL | ABCELLERA BIOLOGICS INC | 12,521 | $124 | 0.1% | $15.18 | -27.7% | COM | 00288U106 |
| — | SYNLOGIC INC | 68,634 | $65 | 0.0% | $3.89 | — | COM | 87166L100 |
| CERS | CERUS CORP | 14,172 | $51 | 0.0% | $5.54 | -13.6% | COM | 157085101 |
| — | INVITAE CORP | 11,337 | $28 | 0.0% | $32.19 | — | COM | 46185L103 |